Back Back
Cell No. : Cell Name
RCB3541 : ATL-72/2(+)  update : 2022/11/18
CommentCurrently not ready. ATL patient derived non-leukemic cell line (IL-2 dependent).
Comment from the depositorATL patient derived non-leukemic cell line (IL-2 dependent). ATL-72/2, ATL-72b, ATL-72T cell lines were established from the same patient's blood.
Terms and conditions
Order Form
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (
Basic information Expected time Upon a request we will start preparation. Contact us:
Cellosaurus(Expasy) CVCL_A6TA
Reference information Reference 2
User's Publication 0

To topTop
3175  Michiyuki Maeda, Junko Tanabe-Shibuya, Paola Miyazato, Hiroshi Masutani, Jun-Ichirou Yasunaga, Kazumasa Usami, Akira Shimizu, Masao Matsuoka  IL-2/IL-2 Receptor Pathway Plays a Crucial Role in the Growth and Malignant Transformation of HTLV-1-Infected T Cells to Develop Adult T-Cell Leukemia  Front Microbiol  2020  11:356  PubMed ID: 32210945   DOI: 10.3389/fmicb.2020.00356
2508  Matsuoka S, Ishii Y, Nakao A, Abe M, Ohtsuji N, Momose S, Jin H, Arase H, Sugimoto K, Nakauchi Y, Masutani H, Maeda M, Yagita H, Komatsu N, Hino O.  Establishment of a Therapeutic Anti-Pan HLA-Class II Monoclonal Antibody That Directly Induces Lymphoma Cell Death via Large Pore Formation  PLoS One  2016  11(3):e0150496.  PubMed ID: 27028595   DOI: 10.1371/journal.pone.0150496

To topTop
User's Publication

Back Back Return Top Page